| EN 1040 | EN 13727 |
Basic conditions | Representative use conditions | |
Mandatory strains | S. aureus P. aeruginosa | S. aureus P. aeruginosa E. coli E. hirae |
Additional strains* | 12 Gram+ 11 Gram− | 11 Gram+ 10 Gram− |
Composition of the tested antiseptic | Foaming solution including 0.2% benzalkonium chloride (CBK) and 0.5% chlorhexidine digluconate (CHX) (Dermobacter®) | |
Concentrations of the antiseptic solution tested | Pure (97%/80%) or diluted (10%) | |
Interfering substances | - | Sheep erythrocytes (3 mL∙L−1) + bovine serum albumin (3 g∙L−1) |
Contact time/T˚ | 1 min at 20˚C | |
Bactericidal activity: log reduction required | ≥ 5 |